APrevent Medical

Executive Summary

APrevent Medical is an Austrian medical device company founded in 2013, dedicated to developing innovative solutions for voice and speech disorders. The company offers a dual-platform approach: an adjustable laryngeal implant system for minimally invasive surgical intervention and a speech conversion SaaS platform for post-operative voice rehabilitation. Headquartered in Vienna with a subsidiary in Taipei, Taiwan, APrevent aims to improve patient quality of life through physician-friendly technologies. While the company is private and financial details are undisclosed, its focus on a niche but growing market—voice disorders—positions it for potential growth as awareness and treatment options expand.

Upcoming Catalysts (preview)

• Q4 2026CE Mark Approval for Next-Generation Laryngeal Implant60% success
• Q1 2027Clinical Trial Results for Voice Recovery SaaS Platform50% success
• Q3 2026Strategic Partnership with Major ENT Clinic Network40% success